Active substanceCyclopyroxCyclopyrox Similar drugsTo uncover Batrafen® cream externally Sanofi India Limited India Batrafen® solution externally Sanofi-Aventis Deutschland GmbH Germany Daphnejin cream the vagina. Polikem Sr.L. Italy Daphnejin suppositories the vagina. Polikem Sr.L. Italy Fonzial® solution locally Pierre Fabre Medication Production France Cyclopoli® solution locally externally Polikhem S.A. Luxembourg Dosage form: & nbspcream for external use Composition:In 1 g of cream contains: Active substance: cyclopyroxa olamine 10 mg. Excipients: benzyl alcohol, paraffin liquid, stearyl alcohol, cetyl alcohol, myristyl alcohol, polysorbate 60, sorbitan stearate, lactic acid, purified water. Description:Cream from almost white to white. Pharmacotherapeutic group:Antifungal medication for external use ATX: & nbspD.01.A.E Other antifungal agents for external useD.01.A.E.14 Cyclopyrox Pharmacodynamics:Batrafen is a broad-spectrum antifungal agent with good penetrating ability. Active substance cyclopyrox olamine is effective against dermatomycetes, yeast-like, moldy and other kinds of fungi. Has antibacterial action against gram-positive strains of bacteria, most gram-negative pathogens. Pharmacokinetics:When applied on large surfaces (750 cm2) and for a long time (6 hours or more) can be detected in the blood (1.3% of the dose), 94-97% is bound to plasma proteins, T1/2 is 1.7 hours and is excreted by the kidneys. Indications:Fungal skin lesions. Contraindications:hypersensitivity to the components of the drug;children under 10 years. Because of the lack of clinical experience, Batrafen is not indicated in infants and young children, as well as during pregnancy and lactation. Pregnancy and lactation:Due to the lack of clinical experience, Batrafen is not indicated during pregnancy and lactation. Dosing and Administration:If the doctor is not prescribed otherwise, the Batrafen cream is applied to the affected areas of the skin 2 times / day with subsequent drying. Treatment should continue until the symptoms disappear (usually 2 weeks). To prevent recurrence of the disease, it is recommended to use the drug for another 1-2 weeks after all clinical symptoms have disappeared. Side effects:Rarely itching or burning sensation. With prolonged external use of the drug sensitization phenomena are possible. Interaction:The effect increases antifungal agents for systemic use. Special instructions:Avoid contact with the eyes. Form release / dosage:Cream for external use 1%. Packaging:For 15 g in aluminum tubes, packed in packs of cardboard. Storage conditions:Store at a temperature of not more than + 25 ° C, out of the reach of children! Shelf life:Shelf life - 2 years. After the expiration date, the drug can not be used. Terms of leave from pharmacies:Without recipe Registration number:П N014812 / 01 Date of registration:12.12.2007 / 21.04.2016 Expiration Date:Unlimited The owner of the registration certificate:Sanofi India LimitedSanofi India Limited India Manufacturer: & nbspSANOFI INDIA, Limited India Representation: & nbspSanofi Aventis GroupSanofi Aventis Group Information update date: & nbsp21.01.2017 Illustrated instructions × Illustrated instructions Instructions